Towards Healthcare
Europe Cell Culture Media Market Size Envisioned at USD 1,453.2 Million by 2032

Europe Cell Culture Media Estimated USD 1,453.2 Million Market Size by 2032

Status: Published Category: Biotechnology Insight Code: 5027 Format: PDF / PPT / Excel

The Europe cell culture media market is estimated to grow from USD 771.2 million in 2022 to reach an estimate of USD 1,453.2 million by 2032, at a 6.29% CAGR between 2023 and 2032.

Europe Cell Culture Media Market Size 2023 - 2032

Unlock Infinite Advantages: Subscribe to Annual Membership

The culture medium is the powerhouse that contains several nutrients that aid in the development, proliferation, maintenance, and storage of microbial and other cell types, such as stem cells or other cell lines.

A growth medium, often referred to as a cell culture medium, is a solid, liquid, or semisolid medium that contains a variety of ingredients and nutrients and is used to support the growth, multiplication, maintenance, and storage of microorganisms, plant cells, mammalian cells, and other cell lines.

Ill Effects of COVID-19 on the Europe Cell Culture Media Market

The european market for regenerative therapeutics is anticipated to be significantly impacted by the COVID-19 pandemic. In a 2020 study that appeared in the European Respiratory Journal, researchers found that novel therapeutic approaches, such as cell-based therapies, particularly those that use mesenchymal stem cells, have proven to be secure and effective in treating patients with Acute Respiratory Distress Syndrome (ARDS). The development of stem cell-based therapies for the management of SARS-CoV-2 illness has received increased attention. The market under consideration is anticipated to see a significant impact during the pandemic as a result of the aforementioned factors.

We can conclude, the COVID-19 pandemic has generated several prospects for tissue and cell culture, regenerative medicine, and enhancing clinical trial outcomes in the shortest amount of time. Therefore, it is anticipated that the market for cell culture medium would experience significant growth during the pandemic era and will forecast an accelerating growth rate throughout the following years to improve disease diagnostics and therapies.

What are Influencers Fueling the Current Market Scenario?

New Technologies For Cell-Based Vaccines In Cell Culture

Cell culture technology has become a crucial component of vaccine production in the pharmaceutical sector. The development of vaccinations against polio, rotavirus, hepatitis, smallpox, chickenpox, and rubella is made easier by cell culture technologies. Additionally, the use of cell-based flu vaccinations has been allowed by the US and numerous European countries.

In the past, viruses were harvested and grown inside chicken eggs to create vaccinations, but this procedure was time-consuming. The cell-culture approach is currently being used to generate vaccines, which is far more effective than the conventional approach. The new cell-culture process makes it possible to produce a lot of vaccines quickly. Additionally, we can say that the vaccines made utilizing the cell-culture approach have a longer shelf life.

What are the Hurdles Faced During Market Growth?

Difficult to Afford Treatment Related to Regenerative Medicine and Cell Culture

The high cost of tissue engineering and regenerative medicine restrains the market's expansion for cell culture media. Due to the monopolistic environment created by the limited supply of tissue engineering and regenerative medicine, the developing tissue engineering sector has difficulties. As there is less competition among suppliers, these services result in increased costs. 

Open doors for Cell Culture Media Market

Evolution Of 3D Cell Culture

An artificial environment where biological cells are permitted to interact or develop with their surroundings is referred to as three-dimensional cell culture. Compared to cells grown in a 2D environment, those in a 3D environment tend to undergo larger physiological and morphological alterations. Researchers claim that this cellular makeup not only boosts gene expression but also cell-cell communication.

Market Scope and Categorization
Europe Cell Culture Media Market Revenue, By Physical State, 2018-2030 The Europe cell culture media market was valued at $498.4 million in 2018 and is projected to reach $1,316.8 million by 2030, growing at a CAGR of 8.5% from 2021 to 2030. Liquid Culture Media was the highest contributor to this market, with $277.8 million in 2018, and is anticipated to reach $722.1 million by 2030.
Europe Cell Culture Media Market Revenue, By Product, 2018-2030

Serum-free media are media designed to grow a specific cell type or perform a specific application in the absence of serum.Europe Cell Culture media Market Revenue, By Application, 2018-2030

Europe Cell Culture Media Market Revenue, By End User, 2018-2030

Due to the growing advancements in the fields of gene therapy and cell therapy, pharmaceutical, and biotechnology companies dominate the global market for cell culture media.

Country Wise Comparison 

Europe is one of the top markets for cell and gene therapy, accounting for the second largest position internationally, with France and the United Kingdom leading the way. France is the European scaffold technology, cell culture, and media market leader. France's dominance was also dictated by the world's leading biotech and research hubs that are currently active in gene and cell therapy. Aside from that, the French government has resolved to boost gene therapy development by easing the acceptance of clinical trials since it was first described in human genome maps in 1990-92. Furthermore, the government encourages the collaboration of small gene therapy research facilities and hospitals, which encourages industry partners to invest in gene therapy initiatives.Europe Cell Culture Media Revenue, By Country, 2018 to 2030

Competitive Landscape

Launches Partnerships/ Collaborations/ Agreement
In October 2021, Thermo Fisher Scientific Inc. today announced the launch of Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, a GMP-manufactured cell culture medium that supports large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells. In June 2020, Corning Incorporated announced the launch of Corning Matrigel matrix-3D plates, pre-dispensed with Matrigel matrix to provide a more consistent and convenient, ready-to-use cell culture option to support organoid and spheroid culture models.

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y.Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.


Cell culture media is a nutrient-rich solution that provides the necessary nutrients, growth factors, and signaling molecules for the growth and proliferation of cells in vitro (in a laboratory setting outside of a living organism). It is used to support the growth and survival of a wide range of cell types, including animal, plant, fungal, and bacterial cells.

The types of cell culture media are basal media, serum-free media, chemically-defined media, specialty media, co-culture media.

The europe cell culture media market revenue was accounted at $498.4 million in 2018 and is expected to surpass around $1,316.8 million by 2030.

The europe cell culture media market is expected to hit at a CAGR of 8.5% from 2021 to 2030.